NK

Neeraj Kumar

Active Director Director DIN 09133323
DIN 09133323 First appointment Apr 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Neeraj Kumar

Data last updated:

Neeraj Kumar is a Director at Nivera Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Nivera Pharmaceuticals Private Limited reported revenue of ₹8,031 (FY 2023).

DIN 09133323
Primary Designation Director
Industry Pharma
First Appointment 05 Apr 2021
Oldest Company Age 5 yrs
Largest company Nivera Pharmaceuticals Private Limited · ₹8,031 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Apr 20212021₹8,031 (FY 2023)Active

Board colleagues of Neeraj Kumar

NameDINCompanyDesignation
Bahadur Padma09133324Nivera Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nivera Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neeraj Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Kumar

Neeraj Kumar currently holds 1 directorship: Nivera Pharmaceuticals Private Limited (Director, since 05 Apr 2021, revenue ₹8,031 (FY 2023)).

Neeraj Kumar was first appointed on 05 Apr 2021 as Director at Nivera Pharmaceuticals Private Limited.

The current boards of Neeraj Kumar's companies include Bahadur Padma (Nivera Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available